Results 321 to 330 of about 398,911 (393)

Visual DAT‐SPECT Outperforms Semiquantitative Analysis in a “Pseudo‐SWEDD” Case of Benign Tremulous Parkinsonism

Movement Disorders Clinical Practice, EarlyView.
Daniele Birreci, Luca Angelini, Martina De Riggi, Simone Aloisio, Adriana Martini, Sofia A. Grandolfo, Luca Marsili, Roberto Cilia, Alberto J. Espay, Matteo Bologna   +9 more
wiley   +1 more source

Movement Disorders Associated with 22q11.2 Microdeletion: A Scoping Review

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Movement disorders have recently emerged as important neurologic manifestations of the 22q11.2 microdeletion that affects nearly one in every 2000 live births. Objective We aimed to map the existing evidence regarding the spectrum, diagnosis and treatment, and etiopathogenesis of movement disorders associated with 22q11.2 ...
Nikolai Gil D. Reyes, Daniel G. Di Luca, Connie Marras, Erik Boot, Ryan K.C. Yuen, Anthony E. Lang, Anne S. Bassett   +6 more
wiley   +1 more source

Are we ready for a biological diagnosis of Parkinson's Disease? [PDF]

Cell Death Dis
Cimmino AT, Di Lazzaro G, Pisani A, Bentivoglio AR, Calabresi P.   +4 more
europepmc   +1 more source

The G2019S LRRK2 mutation exacerbates α-synuclein and tau neuropathology through divergent pathways in Parkinson's disease models. [PDF]

Acta Neuropathol
Tsafaras G, Cabezudo D, Wetzels L, Tsakogias I, Abey A, Bentea E, Sanchiz-Calvo M, Van den Haute C, Wade-Martins R, Baekelandt V.   +9 more
europepmc   +1 more source

An Unusual Motor OFF in Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Shreyashi Jha, Mandar S. Jog
wiley   +1 more source

Low β predicts motor output and cell degeneration in the A53T Parkinson's disease rat model. [PDF]

Brain
Hofman K, Chen J, Sil T, Pellegrini F, Haufe S, Pozzi N, Palmisano C, Isaias IU, Koprich JB, Brotchie JM, Kühn AA, Matthies C, Reich MM, Muthuraman M, Volkmann J, Ip CW.   +15 more
europepmc   +1 more source

Correction: Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia. [PDF]

Front Public Health
Lewandrowski KU, Blum K, Lewandrowski APL, Thanos PK, Pinhasov A, Sharafshah A, Baron D, Gold MS, Dennen CA, Elman I, Bowirrat A, Modestino EJ, Zeine F, Jafari N, Sunder K, Makale MT, Giordano J, Gondre-Lewis MC, Lindenau M, Fuehrlein BS, Badgaiyan RD, Levin C, Schmidt SL, Fiorelli RKA.   +23 more
europepmc   +1 more source

Delayed emergence of parkinson's disease after reversible manganese-induced parkinsonism: a case report. [PDF]

BMC Neurol
Shin HW.
europepmc   +1 more source

Novel Roles for the Ectoenzyme CD38 in the Maintenance of Transcriptional and Metabolic Homeostasis in Astrocytes. [PDF]

Glia
Basak S, Colafrancesco AM, Hernandez RD, Wei X, McMeekin LJ, Dang D, Simmons M, Browning JL, Noel K, Zhou F, Lund FE, Saad JS, Watsen SG, Pickrell AM, Cowell RM, Olsen ML.   +15 more
europepmc   +1 more source

Another Microlesion Effect after STN‐DBS for Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Atsushi Umemura, Genko Oyama, Kenya Nishioka, Nobutaka Hattori   +3 more
wiley   +1 more source